| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915917 | Nuclear Medicine and Biology | 2015 | 11 Pages |
Abstract
[18F]-FNM appears to be a promising tracer for imaging NMDAr activity for undertaking preclinical studies in perspective of clinical detection of neurological or neuropsychological disorders
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors](/preview/png/10915917.png "First Page Preview: Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors")
Authors
Anne-Sophie Salabert, Caroline Fonta, Charlotte Fontan, Djilali Adel, Mathieu Alonso, Carine Pestourie, Hafid Belhadj-Tahar, Mathieu Tafani, Pierre Payoux,